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The Role of High Density Lipoproteins in the Biodistribution of Two Radioiodinated Probes 
in the Rat. POHLAND, R. C., AND COUNSELL, R. E. (1985). Toxicol. Appl. Pharmacol. 77, 47- 
57. Two radioiodinated probes, ‘%cholesteryl oleate (‘251-CO), a derivative of a natural 
constituent of lipoproteins, and l-(2-chlorophenyl)-1-(4[‘25I]iodopheny1>2,2-dichloroethane 
(‘%DDD), an analog of the adrenolytic drug o,p’-DDD (mitotane), were selected to study the 
role of lipoproteins in drug disposition and to examine the ability of these vehicles to direct 
foreign molecules to specific tissues. In vivo and in vitro techniques were utilized to associate 
these probes with rat high density lipoproteins (HDL). Tissue distribution studies indicated 
that prior incorporation of ‘*%CO into rat HDL increased the uptake of ‘251-C0 by rat adrenal, 
which was dramatically enhanced when this preparation was administered to animals made 
hypolipidemic with 4-aminopyrazolo-(3,4)-pyrimidine (CAPP). Acetylation of HDL labeled 
with ‘2sI-C0 provided evidence that the observed uptake into the adrenal was via a receptor- 
mediated process. In contrast with these results, prior association of ‘*‘I-DDD with rat HDL 
failed to alter the ability of this compound to accumulate in adrenal tissue of normal or 
hypolipidemic animals. Polyacrylamide gel electrophoresis (PAGE) was utilized to examine the 
stability of the association of ‘%CO and ‘*‘I-DDD with rat HDL. These results suggested that 
‘251-C0 was associated with the lipophilic core of HDL, whereas ‘*‘I-DDD appeared to be 
partially associated with the suface components of HDL. Saturation of surface components 
with stable o,p’-DDD offered data to suggest that this binding to apoproteins may disrupt the 
normal receptor-mediated uptake process. These studies indicate that lipoproteins may effect 
the distribution and tissue uptake of lipophilic compounds and, conversely, lipophilic molecules 
can effect the metabolic fate of lipoproteins. The overall result is dependent upon the nature 
of the association of these lipophilic compounds with lipoproteins which is difficult to predict 
on the basis of molecular structure alone. 0 1985 Academic press, 1~. 
Plasma lipoproteins consist of water-soluble 
complexes composed of a lipid core sur- 
rounded by surface phospholipids and apo- 
proteins and are primarily responsible for 
transporting lipids such as triglycerides and 
cholesteryl esters to the various organs and 
tissues of the body. While extensive research 
has been performed dealing with serum al- 
bumin and its role in the transport of nu- 
merous endogenous and exogenous com- 
pounds (Kragh-Hansen, 1981), few studies 
have examined the role of plasma lipoproteins 
in the transport and delivery of foreign com- 
pounds. Nonetheless, the possible importance 
of lipoprotein binding or interaction with 
certain lipophilic compounds has been rec- 
ognized. For example, recent studies have 
indicated that the interaction between lipo- 
proteins and a variety of lipophilic com- 
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1975), A’-tetrahydrocannabinol (Klausner et 
al., 1975), benzo[a]pyrene (Shu and Nichols, 
1979, 198 1; Busbee et al., 1982), polychlori- 
nated biphenyls (Becker and Gamble, 1982), 
and chloroethylnitrosoureas (Weinkom et al., 
1980)] involves partitioning of these lipophilic 
agents into the hydrophobic core of lipopro- 
teins. Furthermore, Marinovich et al. (1983) 
have proposed that the binding of 2,3,7,8- 
tetrachlorodibenzodioxin (TCDD) to plasma 
lipoproteins may actually delay the toxicity 
of this agent in experimental hyperlipidemia. 
It is these and similar observations that have 
lead to the possibility that plasma lipoproteins 
may play a significant role in the transport 
of nonpolar, lipophilic compounds. 
The involvement of lipoproteins in phar- 
macokinetics becomes even more pertinent 
in light of recent findings (Brown and Gold- 
stein, 1976; Brown et al., 1981) that indicate 
that these macromolecular complexes are 
taken up into specific cells by receptor-me- 
diated processes. This process, first described 
in human fibroblasts, involves the binding of 
low density lipoproteins (LDL) to specialized 
membrane receptors. This specific binding to 
the receptor is transferred through the rec- 
ognition apoproteins located on the surface 
of LDL. Once binding has occurred, the 
LDL-receptor complex is rapidly internalized 
by endocytosis. The importance of the various 
apoproteins in mediating the specific binding 
of lipoproteins has been demonstrated by 
chemically modifying the lysine residues of 
the lipoproteins by acetylation with diketene 
or acetic anhydride (Weisgraber et al., 1978). 
Such modification has been shown to abolish 
LDL binding and uptake via this specific 
receptor-mediated process. 
According to currrent concepts, tissues re- 
sponsible for the biosynthesis of steroid hor- 
mones derive their cholesterol from three 
possible sources, namely, (1) circulating 
plasma lipoproteins, (2) hydrolysis of intra- 
cellular cholesteryl esters, and (3) intracellular 
biosynthesis. In man, LDL are the major 
carrier of plasma cholesterol to extrahepatic 
tissues. However, studies with rats indicate 
that the adrenal cortex relies mainly upon 
circulating high density lipoproteins (HDL) 
as the source of cholesterol (Anderson and 
Dietschy, 1978; Carr et al., 1980; Faust et 
al., 1977; Balasubramaniam et al., 1977b). 
Once this source becomes depleted, as occurs 
upon treatment of rats with 4-aminopyra- 
zolo[3,4-dlpyrimidine (CAPP), the adrenal 
gland increases the number of lipoprotein 
surface receptors, allowing increased uptake 
of the remaining circulating lipoproteins. 
Furthermore, intracellular cholesterol bio- 
synthesis as well as hydrolysis of intracellular 
cholesteryl esters increases. 
Utilizing the above information, this pro- 
ject was developed to study the role of lipo- 
proteins in the transport and delivery of 
foreign molecules to the adrenal gland. Two 
radioiodinated tracers were selected for this 
study. One was a radioiodinated analog of 
mitotane (o,p’-DDD) a drug which markedly 
affects adrenal function and is used clinically 
to treat adrenal carcinoma, and the other 
was a radioiodinated analog of cholesteryl 
oleate, a normal constituent of the lipophilic 
core of lipoproteins (Fig. 1). Radioiodinated 
(‘251) probes were selected on the basis of 
their ease of preparation and ease of detection 
in subsequent tissue analyses. 
These radioiodinated compounds were 
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FIG. 1. Structures of ‘%CO, unlabeled DDD, and 
‘=I-DDD. 
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utilized to study the role of lipoproteins in 
drug disposition, in general, and transport to 
the adrenal, specifically, by incorporating 
these probes into rat HDL prior to their 
administration to normal rats or to rats made 
hypolipidemic by treatment with 4-APP. 
METHODS 
Animals. Female Sprague-Dawley rats (Spartan Re- 
search Animals, Inc.) weighing 200 to 260 g were used 
in all experiments. The rats were housed in temperature- 
and light-controlled quarters and had free access to feed 
(Teklad 4% rat and mouse diet) and water. 
Radioiodinated DDD. 1-(2-Chlorophenyl)-I-(4-iodo- 
phenyl)-2,2dichIoroethane (I-DDD) was radioiodinated 
(rZ51-DDD) as described previously (CounselI et al., 1967), 
except for the use of the acetamide melt procedure 
(Seevers and Counsell, 1982) for the exchange reaction. 
Radiochemical purity was determined by thin-layer 
chromatography (TLC) using silica gel plates (Eastman 
Kodak) developed in hexane: I-butanol:acetic acid 
(85:5: 10 v/v). Stable I-DDD standard was visualized by 
uv light, and the plate was scanned for radioactivity 
using a Berthold radiochromatogram scanner, Model 
LB2723. This analysis revealed a single radioactive peak 
coincident with the standard. 
Radioiodinated cholesteryl oleate. [ 1 9-‘251]Iodocho- 
lesteryl oleate (‘251-CO) was prepared as previously de- 
scribed (Nordblom et al., 1980) and stored as an oil at 
0°C until used. Radiochemical purity was determined 
by TLC as described above in the solvent system of 
txmzene:ethyl acetate (9: 1 v/v). The plates were developed 
in iodine vapor and scanned for radioactivity as previously 
described. In ah analyses, the single radioactive peak was 
coincident with the standard visualized with iodine vapor. 
In vitro preparation of HDL labeled with lz51-DDD 
(“‘I-DDD-HDL). Rat HDL were isolated from plasma 
according to the method of Have1 et al. (1955). Very 
low density lipoproteins (VLDL) and LDL were first 
isolated in one fraction by adjusting the density of 
plasma to 1.070 with RBr and centrifuging for 20 hr at 
100,OOOg. HDL were then isolated by adjusting the 
density of the remaining solution to 1.2 10 with KBr and 
centrifuging for 45 hr at 100,OOOg. The isolated HDL 
were then dialyzed overnight against 4 liters of 5 mM 
Tris buffer with 1 mM EDTA at pH 7.4, to remove the 
high concentration of salt. Purity of the isolated HDL 
was verified by polyacrylamide gel electrophoresis (PAGE) 
analysis (see below). Protein concentration of isolated 
HDL was determined following the modified Lowry 
procedure of Markwell et al. (I 978). 
1251-DDD was allowed to interact with HDL in a 
manner similar to that described by Shu and Nichols 
(1979). ‘251-DDD (391.0 &i, 2.58 rmol) previously 
immobilized on glass beads was incubated with a 4.5-ml 
sample of HDL (19.8 mg protein) for I hr at 37°C. A 
subsequent experiment indicated that maximum uptake 
of compound from glass beads into HDL solution OC- 
curred at 1 hr (74% uptake) when compared to a control 
solution of saline (~3% uptake). 
After incubation, the radioiodinated HDL were then 
subjected to PAGE analysis and lipid extraction-TLC 
(see below) to assure the integrity of both the HDL and 
tracer. 
In vivo preparation of HDL labeled with ‘251-CO(‘z51- 
CO-HDL). Donor rats received iv injections of ‘25I-CO 
(1.2 to 1.4 mCi, 2.30 pmol) via the tail vein in 2.0 to 
2.5 ml of vehicle (see below for formulation). At 0.5 hr 
following injection, the rats were killed by exsanguination 
from the heart while under diethyl ether anesthesia. The 
blood was collected in heparinized Vacutainer tubes and 
centrifuged at low speed for 10 min to obtain plasma. 
Plasma from five rats was pooled (total volume, 9.0 ml), 
and the denisity was adjusted to 1.070 with KBr as 
described above. After ulracentrifugation at 100,OOOg for 
20 hr at 15°C the top 2.0 ml (containing CM, VLDL, 
and LDL) was removed as previously described. The 
remaining infranate was used at ‘251-CO-HDL. In a 
preliminary tissue distribution study, ‘*‘I-CO-HDL ob- 
tained in this manner was compared to an HDL prepa- 
ration that was further purified by ultracentrifugation as 
described above. Since there was no major difference in 
the tissue distribution profiles of these two preparations 
(results not shown), the second centrifugation step was 
omitted in subsequent preparations. This HDL prepa- 
ration was then anaylyzed following the procedures 
described below. 
Modification of HDL labeled with ‘2sI-C0. Chemical 
modification of the surface apoproteins of lipoproteins 
has been shown to prevent recognition by lipoprotein 
receptors (Weisgraber et al., 1978). To determine if the 
uptake of HDL labeled with ‘25I-CO into the adrenal 
was via a receptor-mediated process, HDL were modified 
with acetic anhydride following the procedure of Basu 
et al. (1976). Furthermore, by saturating the surface 
apoproteins with stable o,p’-DDD, one might also observe 
a decrease in the adrenal uptake of ‘r51-CO-HDL. 
Acetylated HDL were prepared by reacting the free 
amino groups of the lipoprotein with acetic anhydride, 
which increased the net negative charge of the lipoprotein 
particle. In a typical preparation, 80 pl of a saturated 
solution of sodium acetate was added to 0.15 M NaCl 
(0.5 to 1.0 ml) containing 0.25 to 0.5 mg HDL protein 
with continuous stirring in an ice-water bath. Next, 
acetic anhydride was added in multiple small aliquots 
(0.2 ~1) over a period of 1 hr with continuous stirring. 
After the addition of a total mass of acetic anhydride 
equal to 1.5 times the mass of protein used, the mixture 
was stirred for an additional 30 min. The reaction 
mixture was then dialyzed overnight at 4°C against 4 
liters of buffer containing 5 mM Tris and 1 mM EDTA 
at pH 7.4. 
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To demonstrate that the surface components of HDL 
could become saturated with stable o,p’-DDD, unlabeled 
HDL were incubated with ‘*‘I-DDD and increasing 
amounts of stable o,p’-DDD. “‘1-DDD and stable o.p’- 
DDD (final mass = 0.01. 0.1, 0.2, 0.5, 1.0. 2.0, 5.0, or 
10.0 mg) were immobilized on glass beads in 5-ml 
volumetric flasks as previously described. Each flask was 
then incubated with either 1.0 ml of HDL (0.5 mg 
protein) or 1.0 ml of saline for I hr at 37°C. After 
incubation, triplicate counting aliquots were taken from 
each flask and the percentages of radioactivity released 
from the glass beads into either the HDL solution or the 
control saline solution was determined. 
Formulation of “‘I-DDD and ‘2sI-C0 for intravenous 
injection. Since 12’I-DDD and ‘251-C0 are insoluble in 
aqueous solutions, these compounds were formulated in 
suspensions utilizing bovine serum albumin (BSA) and 
Tween-saline solutions. respectively. The biodistribution 
of lz51-DDD and ‘251-C0 administered in these standard 
preparations was then compared to their biodisttibution 
when administered in association with lipoproteins. 
‘*‘I-DDD was formulated for injection in a 2% BSA 
solution containing ethanol (10% v/v). “‘I-CO was for- 
mulated immediately prior to injection by the addition 
of Tween vehicle. This vehicle consisted of saline con- 
taining 10% ethanol and 1.6% Tween 80 (polyoxyethyl- 
enesorbitan monooleate, Sigma). Prior to injection, ali- 
quots of the formulated compounds were assayed for 
radioactivity in a well counter. Aliquots were also analyzed 
by TLC as previously described. 
Analysis of radioiodinated HDL. PAGE analysis of 
the HDL preparations was performed as described by 
Narayan (1975). Gels consisted of 3.5 cm of 3.75% (w/ 
v) main gel and I .O cm of 2.5% (w/v) large-pore stacking 
gel. A 50-~1 aliquot of the fraction was mixed with 25 
~1 of Sudan black dye (a lipoprotein prestain) for 1 hr 
and 25 *I of the mixture was applied to the top of the 
stacking gel. The gels were run at 2.5 mA/tube until the 
leading band migrated 1.7 cm into the main gel. The 
gels were sliced into regions corresponding to lipoprotein 
bands as described by Narayan ( 1975): region 1, stacking 
gel CM; region 2, main gel VLDL/LDL, region 3, main 
gel HDL, region 4, main gel albumin; and region 5, 
main gel area below albumin. The regions were assayed 
for radioactivity in a well counter. 
Additionally, to ascertain the stability of “‘1-DDD 
and ‘251-C0 under the conditions of lipoprotein incor- 
poration, 0. I-ml aliquots of “‘1-DDD-HDL were mixed 
with 0.4 ml distilled water and extracted with chloro- 
fotmmethanol (2: 1, v/v) as described by Folch et al. 
(1957). The lipid extracts were then analyzed by TLC 
using the following systems to assess the percentage of 
radioactivity corn&rating with the parent reference stan- 
dard: 12’I-DDD, hexane: I-butanol:acetic acid (85:5: 10 v/ 
v); ‘2sI-C0, benzene:ethyl acetate (9: 1 v/v). 
Preparation of hypolipidemic rats. To determine the 
effect of lowering circulating plasma lipoprotein concen- 
trations on the biodistribution of the radiolabeled HDL 
preparations, rats received a daily ip injection of a 
solution of 4-aminopyrazolo[3,4-dlpyrimidine (Sigma) 
in 10 mM sodium phosphate at pH 3.3 (Shiff et al.. 
1971; Balasubramaniam et al.. 1977a). The dose was 40 
mg/kg body weight per day for 3 days. 
Tissue distribution of radioactivity after administration 
of “‘I-DDD, “‘I-DDD-HDL, “‘I-CO, or “‘I-CO-HDL 
to normal and hypolipidemic rats. Groups of normal 
and 4-APP-treated rats each received 0.5 ml of ‘*‘I- 
DDD, ‘251-DDD-HDL, “‘I-CO, or ‘251-CO-HDL. The 
amount of radioactivity administered to each group was 
as follows: (1) “‘1-DDD in 2% BSA vehicle, normal 
(12.1 &i, 0.27 rmol). 4-APP treated (7.6 rCi, 0.15 
pmol): (2) lz51-DDD-HDL, normal (6.6 &i), 4-APP 
treated (6.6 &i); (3) ‘251-C0 in Tween-saline vehicle, 
normal ( 13.6 PCi, 0.18 rmol), 4-APP treated ( 11.9 rCi, 
0.04 pmol); (4) ‘251-CO-HDL, normal (7.5 rCi), 4-APP 
treated (0.9 PCi). At least three animals were used in 
each group, and animals were killed at 5, 15. 30, and 60 
min after injection by exsanguination from the heart. 
The blood was collected in heparinized Vacutainer tubes. 
Samples of whole blood were taken for counting, and 
the remaining blood centrifuged at low speed for 10 min 
to obtain plasma. The following organs were removed, 
rinsed of blood. and blotted dry: adrenal cortex, liver, 
ovaries, and thyroid. Large organs were minced with 
scissors. Samples were transferred to tared cellulose 
acetate capsules, weighed, and placed in polystyrene 
gamma tubes. Aliquots of plasma from all rats were 
analyzed by PAGE analysis as described above. Statistical 
analysis of the data were performed utilizing Student’s t 
test. 
Measurement of in vitro transfer of radioiodinated 
probes from HDL following incubation with plasma 
components. To examine the stability of the association 
of lZ51-DDD and ‘251-C0 with HDL, ‘251-DDD-HDL 
and ‘251-CO-HDL were incubated with plasma. A 0.5- 
ml aliquot of lz51-DDD-HDL (10.9 PCi) was incubated 
with 6.0 ml rat plasma at 37°C in a water bath with 
agitation. At 5, 15, 30, and 60 mitt, 25-~1 aliquots of the 
incubation medium were taken and analyzed by PAGE 
as previously described. 
Since the ‘251-CO-HDL preparation contained all of 
the plasma components except the VLDL/LDL fraction 
which had previously been removed, ‘251-CO-HDL was 
incubated with rat lipoproteins of density < 1.070 (VLDL 
+ LDL). This incubation medium contained essentially 
the reconstituted components of rat plasma. Rat hpopro- 
teins of density < 1.070 were isolated as previously 
described. A 2.0-ml aliquot of this fraction was incubated 
with 0.5 ml of the ‘251-CG-HDL preparation as described 
above. At 0.5, 1, 3, and 24 hr, 25-~1 ahquots of the 
incubation medium were analyzed as mentioned above. 
Tissue distribution of radioactivity afier administration 
of modified HDL labeled with “‘I-CO to normal and 
hypolipidemic rats. Groups of rats treated with 4-APP 
received 0.3 ml of acetyl-‘251-CO-HDL or DDD-lz51- 
CO-HDL. Animals received either 2.0 &i of acetyl-‘251- 
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CO-HDL or 1.6 &i of DDD-‘?-CO-HDL. Three 
animals were used in each of the 4-APP-treated groups. 
Animals were killed at 15 min after injection by exsan- 
guination from the heart. The tissue distribution of these 
modified HDL preparations was performed as described 
above. Statistical analysis of the data was performed 
utilizing Student’s t test. 
RESULTS 
Administration of 1251-C0 to donor rats 
resulted in the appearance of approximately 
5% of the dose in the HDL fraction within 
0.5 hr. Ultracentrifugal separation gave an 
HDL fraction which upon gel electrophoresis 
showed the majority of radioactivity (>91%) 
to be associated with the HDL region. More- 
over, lipid extraction of this HDL fraction 
and subsequent TLC analysis revealed that 
over 90% of the radioactivity remained as- 
sociated with 1251-C0. 
The tissue distribution profile of ‘251-C0 
and ‘251-CO-HDL is illustrated in Fig. 2. 
The uptake of radioactivity into the adrenal 
cortex significantly increased with both nor- 
mal and hypolipidemic animals when HDL 
were labeled with ‘251-C0. In untreated ani- 
mals there was a 4-fold increase in the adrenal 
uptake following administration of 1251-CO- 
HDL, as compared to ‘251-C0 in a Tween- 
saline vehicle. However, in 4-APP-treated 
animals, there was a 27-fold increase in the 
adrenal uptake when 1251-CO-HDL was 
compared to ‘251-C0. 
Incubation of HDL with ‘251-DDD previ- 
ously immobilized on glass beads resulted in 
the transfer of >77% of the initial radioactiv- 
ity into the HDL phase. PAGE analysis of 
“‘1-DDD-HDL showed that >94% of the 
radioactivity migrated with the HDL band. 
Moreover, lipid extraction of ‘251-DDD-HDL 
and subsequent TLC analysis revealed that 
over 95% of the radioactivity was still bound 
to the parent compound. 
Figure 3 illustrates the tissue uptake of 
1251-DDD and ‘251-DDD-HDL at 15 min 
postinjection in normal and hypolipidemic 
rats. The highest percentage of radioactivity 











FIG. 2. Tissue uptake of ‘251-C0 and ‘ZSI-CO-HDL at 
15 min postinjection in normal and hypolipidemic rats. 
‘*?-CO or iZ51-CO-HDL was administered to either 
untreated or 4-APP-treated (40 mg/kg body wt/day for 
3 days, ip) rats. At 15 min postinjection, the rats were 
exsanguinated and the tissues removed, weighed, and 
analyzed for radioactivity. All values are expressed as 
the mean percentages of administered dose/g tissue 
? SE. For comparison, the percentages of the administered 
dose/organ for adrenal cortex in untreated and 4-APP- 
treated rats following administration of “‘1-CO-HDL 
were 0.59 f  0.07 and 10.71 + 1.65, respectively. The 
liver values were 28.56 + 1.71 and 16.10 + 0.70, 
respectively. *p < 0.01 for ‘251-C0 as compared to ‘251- 
CO-HDL for each tissue and treatment. 
cortex at this time point in both untreated 
and 4-APP-treated animals. It was also noted 
that this time period coincided with the peak 
concentration of radioactivity in the adrenal 
cortex for both preparations in normal ani- 
mals. However, in hypolipidemic animals, 
the peak concentration of radioactivity in the 
adrenal cortex for both preparations was 5 
min postinjection and was similar to the 
value obtained at 15 min in normal animals 
(data not shown). Furthermore, there was no 
significant difference in the tissue distribution 
for all tissues within treatment groups when 
1251-DDD was administered associated with 
HDL or in a 2% BSA vehicle (Fig. 3). 
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FIG. 3. Tissue uptake of “‘1-DDD and lz51-DDD- 
HDL at 15 min postinjection in normal and hypolipi- 
demic rats. “‘1-DDD or ‘?-DDD-HDL was intrave- 
nously administered to either untreated or 4-APP-treated 
adult female Sprague-Dawley rats. Tissue distribution 
was performed as described in Fig. 2. 
Since the adrenal uptake of 1251-CO-HDL 
was dramatically greater than that observed 
for ‘251-DDD-HDL, the stability of the as- 
sociation of ‘251-C0 and ‘251-DDD with HDL 
was examined in vivo and in vitro. PAGE 
analysis of ‘251-CO-HDL prior to adminis- 
tration to normal rats indicated that 88% of 
the radioactivity was located in the HDL 
region (Table 1). Following in vivo adminis- 
tration of “‘1-CO-HDL, a majority of the 
radioactivity remained with the HDL region 
even after 24 hr postinjection. Similar results 
were obtained following in vitro incubation 
of “‘1-CO-HDL with a plasma fraction of d 
< 1.070 (i.e., reconstituted plasma). These 
data support the view that ‘251-C0 is tightly 
associated with HDL and is in all probability 
confined to the lipid core in a manner similar 
to that proposed for other cholesteryl esters. 
PAGE analysis of 1251-DDD-HDL prior 
to administration to normal rats indicated 
that >94% of the radioactivity was located 
in the HDL region (Table 2). However, fol- 
lowing in vivo administration of 1251-DDD- 
HDL, there was a rapid redistribution of 
radioactivity from HDL to other plasma 
components. Similarly, in vitro incubation of 
“‘1-DDD-HDL with whole rat plasma caused 
a rapid redistribution of radioactivity to other 
regions of the gel. These findings suggest that 
a portion of ‘251-DDD is associated with the 
surface components of HDL (i.e., apopro- 
teins). This could account for the observed 
rapid exchange of ‘251-DDD from HDL to 
other plasma components. 
To confirm the participation of 1251-CO- 
HDL in receptor-mediated uptake by the 
adrenal, this preparation was acetylated with 
TABLE 1 
In Vivo AND in Vitro ASXIATION OF ‘*51-C0 WITH PLASMA COMFQNENTS AS DETERMINED BY PAGE 
After in vivo 
administration of “‘I- 
CO-HDL 
Gel region 0 hr 0.5 hr 24 hr 
CM/VLDL 4.2” 0.3 f  O.lb 26.4 
LDL 2.6 3.9 e 0.8 6.0 
HDL 88.0 87.4 + 1.0 60.1 
Albumin 3.6 3.0 + 0.1 3.1 
Below albumin 1.5 5.4 f  0.1 4.3 
After in vitro incubation of 
?-CO-HDL with a plasma 
fraction of d < 1.070 
0.5 hr 24 hr 
7.0 f  1.5 4.6 f  0.8 
5.0 f  0.2 5.4 f  0.5 
82.2 -c 0.2 87.8 f  0.4 
1.0 + 0.4 0.5 + 0.0 
4.7 rfr 0.6 1.6 f  0.1 
a Data are expressed as percentages of total radioactivity in each region, 
b%+SE. 
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TABLE 2 
In Vivo AND in Vitro ASSOCIATION OF ‘*%DDD WITH PLASMA COMPONENTS AS DETERMINED BY PAGE 





Below albumin 0.2 
After in vivo administration of 
‘*‘I-DDD-HDL 
5 mitt 30 min 
21.2 AZ 1.9* 12.0 + 1.6 
11.6 + 1.6 7.4 + 0.4 
25.8 5 2.8 27.0 f 4.3 
40.6 + 4.7 53.4 + 3.0 
0.7 + 0.3 0.2 * 0.2 
After in vitro 
incubation of ‘*% 
DDD-HDL with 
whole plasma 






’ Data are expressed as percentages of total radioactivity in each region. 
bX+_SE. 
acetic anhydride and administered to 4-APP- 
treated rats. This chemical modification of 
the surface apoproteins of HDL prevents 
recognition by lipoprotein receptors (Weis- 
graber et al., 1978). 
As indicated in Fig. 4, when lz51-DDD 
(0.01 mg) was incubated without additional 
stable o,p’-DDD, approximately 90% of the 
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FIG. 4. Incubation of I*?-DDD with increasing amounts 
of stable o.p’-DDD. To demonstrate that the surface 
components of HDL could become saturated with stable 
o,p’-DDD, unlabeled HDL were incubated with “‘I- 
DDD and increasing amounts of stable o,p’-DDD. See 
text for details. 
into the HDL solution as compared to only 
approximately 10% of the radioactivity be- 
coming soluble in saline. PAGE analysis of 
the HDL solution also inidicated that ~70% 
of the radioactivity in solution was associated 
with the HDL component. Furthermore, as 
increasing amounts of stable o,p’-DDD were 
added to ‘251-DDD, less radioactivity became 
associated with HDL. As indicated in Fig. 4, 
HDL became completely saturated as the 
mass of stable o,p’-DDD approached 10 mg. 
At all concentrations of o,p’-DDD, < 10% of 
the radioactivity was released into the saline 
solution. 
These results therefore indicate that 0.5 
mg of HDL protein can become completely 
saturated with o,p’-DDD when incubated 
with 10 mg of this compound. As a result, 
HDL labeled with ‘251-C0 (0.25 mg protein) 
were incubated with 10 mg stable o,p’-DDD 
previously immobilized on glass beads as 
described under Methods. 
Figure 5 illustrates the tissue uptake of 
‘251-CO-HDL, acetyl-‘251-CO-HDL, and 
DDD-‘251-CO-HDL at 15 min postinjection 
in hypolipidemic rats. Acetylation signifi- 
cantly decreased the uptake of 1251-CO-HDL 
into steroid-secreting tissues of hypolipidemic 
rats. Furthermore, saturation of ‘251-CO-HDL 
with o,p’-DDD (DDD-1251-CO-HDL) ap- 
peared to slightly perturb the uptake of ra- 
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*  eCETYL-‘251-CO-HDL (n-3) -
m DDdZ51-CO-HDL (~31 
FIG. 5. Tissue uptake of “‘1-CO-DDD, acetyl-“‘I- 
CO-HDL, and DDD-‘251-CO-HDL at 15 min postin- 
jection in hypolipidemic rats. ‘%CO-HDL, acetyl-‘2sI- 
CO-HDL, or DDD-1251-CO-HDL was administered as 
in Fig. 2. *p < 0.05 for ‘*‘I-CO-HDL as compared to 
acetyl-‘ZSI-CO-HDL for each tissue. 
dioactivity into these same tissues. However, 
on a statistical basis the tissue uptake of 
DDD-‘2Sl-CO-HDL was not significantly dif- 
ferent from that of ‘251-CO-HDL. The ob- 
servation that saturating 1251-CO-HDL with 
o,p’-DDD only slightly altered adrenal uptake 
is consistent with the rapid redistribution of 
12%DDD from HDL to other plasma com- 
ponents. This rapid loss of u,p’-DDD from 
the surface of ‘*%CO-HDL could account 
for the greater adrenal uptake of radioactivity 
from DDD-‘251-CO-HDL than observed for 
acetyl- ‘251-CO-HDL. 
DISCUSSION 
When 1251-CO-HDL was administered to 
normal rats, its specific activity was immme- 
diately reduced by the endogenous plasma 
lipoproteins. This, in turn, could explain the 
modest increase of uptake of radioactivity by 
the adrenal when ‘251-CO-HDL was admin- 
istered to normal animals. Treatment of rats 
with 4-APP, however, caused a profound 
lowering of circulating lipoprotein concentra- 
tions, thus minimizing dilution of ‘251-CO- 
HDL upon administration. Moreover, this 
decrease in circulating lipoproteins could also 
cause an increase in the number of HDL 
receptors in target tissues, which is consistent 
with the known regulation of adrenal activity 
(Brown et al., 198 1; Balasubramaniam et al., 
1977b; Pittman et al., 1982). Both or either 
one of these possibilities could account for 
the dramatic increase in adrenal uptake of 
‘251-CO-HDL in the hypolipidemic animals. 
On the basis of these studies, it appears 
that the association of these lipophilic com- 
pounds with HDL depends upon their mo- 
lecular properties. It is proposed that ‘251-C0 
becomes incorporated into the lipophilic core 
of HDL and that the resulting ‘251-CO-labeled 
HDL are capable of participating in the 
normal receptor-mediated uptake process 
characteristic of the adrenal. On the other 
hand, the results of this study suggest that 
1251-DDD associates with the surface as well 
as the core components of HDL. Such bind- 
ing of drugs to the surface apoproteins could 
perturb the normal receptor-mediated uptake 
process. 
In a preliminary experiment, the electro- 
phoretic migration of unlabeled HDL treated 
with only sodium acetate was compared to 
HDL treated with both sodium acetate and 
acetic anhydride. As seen in Fig. 6, PAGE 
analysis indicated that treatment of HDL 
with sodium acetate alone did not alter the 
gel migration pattern when compared to that 
of untreated control HDL. On the other 
hand, treatment of HDL with sodium acetate 
and acetic anhydride resulted in an altered 
gel migration pattern. The acetylated HDL 
appeared to migrate more rapidly toward the 
cathode, which is consistent with results ob- 
tained by Basu et al. (1976). HDL labeled 
with ‘251-C0 were then acetylated with acetic 
HDL 
unsuccessful with patients undergoing treat- 
ment with o,p’-DDD (Gross et al., 1981). 
In conclusion, this study has shown that 
lipophilic compounds become associated with 
lipoproteins and that the nature of this as- 
sociation depends upon molecular properties 
that are not readily apparent. Lipophilic 
FIG. 6. PAGE analysis of acetylated HDL was per- compounds may become incorporated into 
formed on (1) untreated rat HDL, (2) rat HDL treated the lipophilic core of lipoproteins and/or 
with sodium acetate, and (3) rat HDL treated with 
sodium acetate and acetic anhydride. 
bind to their surface components. Moreover, 
compounds which become incorporated into 
the core of lipoproteins may participate in 
anhydride (acetyl-I*?-CO-HDL) and the tis- receptor-mediated uptake into tissues such 
sue distribution of these modified HDL was as the adrenal and thereby accumulate in 
compared to the tissue distribution of ‘*‘I- such tissues. On the other hand, drugs that 
CO-HDL. PAGE analysis of 1251-CO-HDL bind to the surface apoproteins of lipoproteins 
incubated with acetic anhydride indicated may interfere with the normal receptor-me- 
that the acetylated ‘*‘I-CO-HDL (acetyl-‘251- diated processes and thereby alter the meta- 
CO-HDL) migrated more rapidly toward the bolic fate of plasma lipoproteins. On the 
cathode. Furthermore, when the gel was sliced basis of this study, the effect of lipoproteins 
and counted, the majority of the radioactivity on drug disposition and transport as well as 
was found associated with the more rapidly the effect of drugs on lipoprotein metabolism 
migrating band. deserves further examination. 
As previously indicated, results from PAGE 
anaylsis indicated that a significant amount 
of ‘*‘I-DDD was interacting with the surface 
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